What action is being taken to support the 20% of UK clinical research which is stated by the Association of the British Pharmaceutical Indu…

Answered Asked by Mary Scanlon Con Lodged 7 Mar 2002

The question

To ask the Scottish Executive what action is being taken to support the 20% of UK clinical research which is stated by the Association of the British Pharmaceutical Industry to be based in Scotland in order to ensure long-term stability for the industry and diversity of the economy.

The answer

Answered by Malcolm Chisholm on 20 Mar 2002 · 13 days after it was lodged, on time

The Executive supports the conclusions of the Pharmaceutical Industry Competitiveness Task Force report of March 2001, which seek to ensure that the UK remains at the forefront of clinical research. The Executive will continue to liaise with the Department of Health about progressing issues jointly where appropriate.Issues more appropriately progressed separately in a Scottish context will be taken forward through the Pharmaceutical Liaison Group. This group, chaired by the Chief Scientist, is a forum designed to allow discussion of matters of shared interest to the Scottish Executive Health Department, NHSScotland and pharmaceutical interests. The group plans to meet next in April 2002.

In the Official Report

No contribution in the Official Report cites S1W-23850 by reference.